NCT04417738View on ClinicalTrials.gov

Transcranial Photobiomodulation for the Treatment of Opioid Cravings

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions
Opioid-use DisorderDepression, AnxietyCraving
Interventions
DEVICE

unilateral transcranial photobiomodulation, near infrared mode

The investigators are applying a supra luminous LED at 810 nm and 250 mW/cm2 to the forehead of the participant at F3 and F4.

DEVICE

Sham treatment

The sham treatment is identical to the active treatment except that the sham treatment has a piece of aluminum foil covering the led so that the participant will experience warmth but receive no photons.

Trial Locations (1)

02461

MindLight, LLC, Newton Highlands

All Listed Sponsors
lead

MindLight, LLC

INDUSTRY

NCT04417738 - Transcranial Photobiomodulation for the Treatment of Opioid Cravings | Biotech Hunter | Biotech Hunter